“Phage Therapy” Market Insights | No of Pages120| By Application [Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others], By Type [DsDNA Bacteriophage, ssDNA Bacteriophage, ssRNA Bacteriophage, Others]. The Phage Therapy Market Report offers a comprehensive view of the competitive landscape of the Phage Therapy market and includes a deep description of performance by some of the key global players competing in the market. Moreover, the report offers full information about the position, scope of growth, and prospects of new participants or players in the market.
Who are some of the Top Manufacture operating in the Phage Therapy market and how high is the competition 2022?
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
Short Summery about Phage Therapy Market
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Market Analysis and Insights: Global and United States Phage Therapy Market
This report focuses on global and United States Phage Therapy market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Phage Therapy market size is estimated to be worth USD 38 million in 2022 and is forecast to a readjusted size of USD 100.8 million by 2028 with a CAGR of 17.6% during the review period. Fully considering the economic change by this health crisis, by Type, DsDNA Bacteriophage accounting for % of the Phage Therapy global market in 2021, is projected to value USD million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Animal Health was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Global Phage Therapy Scope and Market Size
Phage Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Phage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Phage Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
PHAGElogist 